Lisinopril was recalled following a March 2015 inspection that determined that more extensive research into complaints about the drug's various dosages was needed before the drug was safe to administer, according to GoodRX. The recalled lots first appeared in pharmacies in July 2012.Continue Reading
There are two ways by which a drug manufacturer can initiate a recall of one of their products: Either the manufacturer voluntarily performs the recall itself, or the Food and Drug Administration requires them to, according to GoodRX. In the case of Lisinopril, Wockhardt, the drug's manufacturer, voluntarily decided that more research is needed before the product is ready to hit the market.
Several classes of recall exist, notes GoodRX. The Lisinopril recall is a class II recall, which means that doctors do not necessarily need to notify their patients, since it may not have an effect on their health. Patients who are concerned about their prescriptions being affected are encouraged to contact their doctors or pharmacists to learn more.
Wockhardt's recall of Lisinopril affects three dosage strengths of the drug: 2.5-milligram tablets, 10-milligram tablets and 20-milligram tablets, according to GoodRX. Specific lots affected include DM10573, DM13052, DM13053 and DN10485. The 2.5-milligram dosage lot has expired, as of the recall date.Learn more about Medications & Vitamins